GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer
NCT01487720
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
GEMOX
Sponsor
Asan Medical Center